Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yeamin Huh

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|November 14, 2015
Application of a hazard-based visual predictive check to evaluate parametric hazard modelsYeamin Huh, Matthew M Hutmacher
CPT: Pharmacometrics & Systems Pharmacology|June 9, 2020
Response Letter to the Editor: "Assumption Checking Before Application of the Prespecified QT Linear Mixed Effect Model is Essential"Yeamin Huh, Steve Riley, Timothy Nicholas
CPT: Pharmacometrics & Systems Pharmacology|January 15, 2025
Population exposure-response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areataYuchen Wang, Yeamin Huh, Alexandre Lejeune
Clinical Pharmacokinetics|February 15, 2024
Moving Beyond Boundaries: Utilization of Longitudinal Exposure-Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development ParadigmYeamin Huh, Jessica Wojciechowski, Vivek S Purohit
British Journal of Clinical Pharmacology|February 15, 2021
Population pharmacokinetic modelling and simulation of tafamidis in healthy subjects and patients with transthyretin amyloidosisYeamin Huh, Steve Riley, Lutz Harnisch, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2013
Impact of lipopolysaccharide-induced inflammation on the disposition of the aminocephalosporin cefadroxilYeamin Huh, Richard F Keep, David E Smith
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 7, 2011
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugsYeamin Huh, David E Smith, Meihau Rose Feng
CPT: Pharmacometrics & Systems Pharmacology|November 22, 2019
Evaluation of QT Liability for PF-05251749 in the Presence of Potential Circadian Rhythm ModificationYeamin Huh, Danny Chen, Steve Riley, et al.
Clinical Pharmacokinetics|November 2, 2023
Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug DevelopmentJessica Wojciechowski, Vivek S Purohit, Yeamin Huh, et al.
Pharmaceutical Research|February 2, 2013
Importance of Peptide transporter 2 on the cerebrospinal fluid efflux kinetics of glycylsarcosine characterized by nonlinear mixed effects modelingYeamin Huh, Scott M Hynes, David E Smith, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Pharmacokinetics and Pharmacodynamics|November 14, 2015
Application of a hazard-based visual predictive check to evaluate parametric hazard modelsYeamin Huh, Matthew M Hutmacher
CPT: Pharmacometrics & Systems Pharmacology|June 9, 2020
Response Letter to the Editor: "Assumption Checking Before Application of the Prespecified QT Linear Mixed Effect Model is Essential"Yeamin Huh, Steve Riley, Timothy Nicholas
CPT: Pharmacometrics & Systems Pharmacology|January 15, 2025
Population exposure-response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areataYuchen Wang, Yeamin Huh, Alexandre Lejeune
Clinical Pharmacokinetics|February 15, 2024
Moving Beyond Boundaries: Utilization of Longitudinal Exposure-Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development ParadigmYeamin Huh, Jessica Wojciechowski, Vivek S Purohit
British Journal of Clinical Pharmacology|February 15, 2021
Population pharmacokinetic modelling and simulation of tafamidis in healthy subjects and patients with transthyretin amyloidosisYeamin Huh, Steve Riley, Lutz Harnisch, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2013
Impact of lipopolysaccharide-induced inflammation on the disposition of the aminocephalosporin cefadroxilYeamin Huh, Richard F Keep, David E Smith
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 7, 2011
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugsYeamin Huh, David E Smith, Meihau Rose Feng
CPT: Pharmacometrics & Systems Pharmacology|November 22, 2019
Evaluation of QT Liability for PF-05251749 in the Presence of Potential Circadian Rhythm ModificationYeamin Huh, Danny Chen, Steve Riley, et al.
Clinical Pharmacokinetics|November 2, 2023
Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug DevelopmentJessica Wojciechowski, Vivek S Purohit, Yeamin Huh, et al.
Pharmaceutical Research|February 2, 2013
Importance of Peptide transporter 2 on the cerebrospinal fluid efflux kinetics of glycylsarcosine characterized by nonlinear mixed effects modelingYeamin Huh, Scott M Hynes, David E Smith, et al.
Pageof 3